UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Greenhouse Solutions Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
39530T103
(CUSIP Number)
Dr. Malireddy S. Reddy
c/o ADFAC/IMAC
1250 S. Parker Road, Suite 203
Denver, CO 80231
303-944-5215
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
January 21, 2015
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box: ____
SCHEDULE 13D
1. NAME OF REPORTING PERSON
Dr. Malireddy S. Reddy
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
a. ___
b. ___
3. SEC USE ONLY
4. SOURCE OF FUNDS
PF
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) ______
6. CITIZENSHIP OR PLACE OF ORGANIZATION
USA
7. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
SOLE VOTING POWER
7,000,000
8. SHARED VOTING POWER
0
9. SOLE DISPOSITIVE POWER
7,000,000
10. SHARED DISPOSITIVE POWER
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,000,000
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES _____
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.8%
14. TYPE OF REPORTING PERSON
IN
ITEM 1. SECURITY AND ISSUER
This statement on Schedule 13D ("Schedule 13D") is being filed with respect to
the common stock, $0.0001 par value (the "common Stock"), of Greenhouse
Solutions Inc., a Nevada corporation (the "Company"). The Company's principal
executive office is located at 8400 E. Crescent Parkway, Suite 600, Greenwood
Village, Colorado 80111.
2
ITEM 2. IDENTITY AND BACKGROUND
(a) This statement is filed by Dr. Malireddy S. Reddy (the "Reporting Person")
with respect to shares directly owned by him.
Any disclosures herein with respect to persons other than the Reporting Person
is made on information and belief after making inquiry to the appropriate party.
(b) The business address of Dr. Malireddy S. Reddy is c/o ADFAC/IMPAC, 1250 S.
Parker Road, Suite 203, Denver, CO 80231.
(c) The Reporting Person has not, during the last five years, been convicted in
a criminal proceeding (excluding traffic violations or similar misdemeanors).
(d) The Reporting Person has not, during the last five years, been a party to a
civil proceeding of a judicial or administrative body of competent jurisdiction
and as a result of such proceeding was or is subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation
with respect to such laws.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
On January 21, 2015, the Reporting Person acquired 7,000,000 shares of the
Company's voting Common Stock issued for a License for certain IP owned by
Reporting Person.
ITEM 4. PURPOSE OF TRANSACTION
The shares of Common Stock owned by the Reporting Person were acquired for, and
are being held for, investment purposes. As discussed above, the shares were
acquired pursuant to a License granted by Reporting Person.
The Reporting Person may in the future directly acquire shares of Common Stock
in open market or private transactions, block purchases or otherwise. The
Reporting Person may continue to hold or dispose of all or some of the
securities reported herein from time to time, in each case in open market or
private transactions, block sales or purchases or otherwise, subject to
compliance with applicable law. Other than as set forth herein, the Reporting
Person has no plans or proposals which relate to, or could result in, any of the
matters referred to in paragraphs (b) through (j), inclusive, of Item 4 of the
Schedule 13D. The Reporting Person may, at any time and from time to time,
review or reconsider his position and formulate plans or proposals with respect
thereto, but has no present intention of doing so.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) As of the close of business on January 21, 2015, the Reporting Person was
the beneficial owner, within the meaning of Rule 13d-3 under the Exchange Act,
of 7,000,000 shares of common Stock. As of January 21, 2015, these shares
represented 7.8% of the voting power of the 88,760,000 total voting shares of
the Company's capital stock outstanding as reported.
(b) The sole or shared power to vote or dispose of, or to direct the vote or
disposition of the Common Stock with respect to each Reporting Person noted in
paragraph (a) of this Item 5 is as set forth on the cover sheets of this
Schedule 13D.
(c) There have been no transactions involving the shares of Common Stock of the
Company engaged in during the 60 day period prior to and including January 21,
2015, up to the present.
3
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER
There are no contracts, arrangements, understandings or relationships (legal or
otherwise) among the Reporting person named in Item 2 of this statement and
between such Reporting Person and any person with respect to any securities of
the Company, including but not limited to transfer or voting of any of the
securities, finder's fees, joint ventures, loan or arrangements, puts or calls,
guarantees of profits, division of profits or loss, or the giving or withholding
of proxies.
A new business direction is being pursued with new management and with equity
participation by new principals. The CEO/Director, Rik Dietsch, has acquired
4,000,000 shares of Common Stock (4.51%) for a Sub-License of certain
proprietary formulations related to CBD Oil and as may be legally allowed,
marijuana products. The President/Director, Redgie Green, has purchased 200,000
shares of Common Stock (0.23%), and Director, John G. Michak, III, has purchased
29,000,000 shares of common Stock (32.7%) from George Dory. Mr. Dory returned
11,000,000 shares of stock to treasury. There is an understanding that the
license and Sub-License provided to the Company by Dr. Reddy and Mr. Dietsch
respectively are conditioned on performance thereunder. Dr. Reddy received
7,000,000 shares as consideration for a License of probiotic formulas for CBD
Oil and marijuana products if legal.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Exhibit 10.1 License Agreement Between Dr. M.S. Reddy and Greenhouse Solutions,
Inc.
4
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete, correct.
/s/ Malireddy S. Reddy
---------------------------------------------
Dr. Malireddy S. Reddy
|
5